BPG is committed to discovery and dissemination of knowledge
Featured Articles
5/10/2024 12:06:35 PM | Browse: 184 | Download: 577
 |
Received |
|
2023-11-30 03:32 |
 |
Peer-Review Started |
|
2023-11-30 03:32 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-02-20 01:53 |
 |
Revised |
|
2024-02-26 15:07 |
 |
Second Decision |
|
2024-04-01 06:41 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-04-01 08:35 |
 |
Articles in Press |
|
2024-04-01 08:35 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-04-23 02:16 |
 |
Publish the Manuscript Online |
|
2024-05-09 13:59 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Medicine, Research & Experimental |
Manuscript Type |
Basic Study |
Article Title |
Epigenetic silencing schlafen-11 sensitizes esophageal cancer to ATM inhibitor
|
Manuscript Source |
Invited Manuscript |
All Author List |
Jing Zhou, Mei-Ying Zhang, Ai-Ai Gao, Cheng Zhu, Tao He, James G Herman and Ming-Zhou Guo |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
National Key Research and Development Program of China |
2018YFA0208902 |
National Science Foundation of China |
U160428,182272632,81672318 |
Beijing Science Foundation of China |
7171008 |
Youth Innovation Science Foundation of Chinese PLA general hospital |
22QNCZ027 |
|
Corresponding Author |
Ming-Zhou Guo, MD, PhD, Professor, Department of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing 100853, China. guomingzhou@301hospital.org |
Key Words |
Schlafen-11; Esophageal squamous cell carcinoma; DNA methylation; Synthetic lethality; AZD0156 |
Core Tip |
Targeting DNA damage repair (DDR) is a novel strategy for cancer therapy. Epigenetic-based synthetic lethality studies have been conducted recently. Schlafen-11 (SLFN11) has been reported to sensitize cancer cells by involving DDR. However, the detailed regulatory network in DDR remains controversial. This study explored the mechanism of SLFN11 in DDR, and further investigated the synthetic lethal efficiency of epigenetic silencing SLFN11 and ATM inhibitor. The results demonstrated that SLFN11 activated non-homologous end-joining and ATR/CHK1, while inhibiting the ATM/CHK2 signaling pathway. Epigenetic silencing SLFN11 sensitized esophageal cancer cells to ATM inhibitor both in vitro and in vivo. |
Publish Date |
2024-05-09 13:59 |
Citation |
Zhou J, Zhang MY, Gao AA, Zhu C, He T, Herman JG, Guo MZ. Epigenetic silencing Schlafen-11 sensitizes esophageal cancer to ATM inhibitor. World J Gastrointest Oncol 2024; 16(5): 2060-2073 |
URL |
https://www.wjgnet.com/1948-5204/full/v16/i5/2060.htm |
DOI |
10.4251/wjgo.v16.i5.2060 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345